TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Astellas Pharma AB
Closing information (x1000 NOK)
Closing information | 2023/03 | 2022/03 | 2021/03 |
Turnover |
44,003
|
38,289
|
46,952 |
Financial expenses |
159
|
674
|
550 |
Earnings before taxes |
2,006
|
1,366
|
2,232 |
EBITDA |
2,165
|
1,404
|
2,372 |
Total assets |
56,356
|
42,078
|
42,567 |
Current assets |
56,356
|
42,078
|
42,567 |
Current liabilities |
18,358
|
10,108
|
9,949 |
Equity capital |
37,998
|
31,969
|
32,619 |
- share capital |
249
|
211
|
220 |
Employees (average) |
16
|
18
|
19 |
Financial ratios
Fiscal year | 2023/03 | 2022/03 | 2021/03 |
Solvency |
67.4%
|
76.0%
|
76.6% |
Turnover per employee |
2,750
|
2,127
|
2,471 |
Profit as a percentage of turnover |
4.6%
|
3.6%
|
4.8% |
Return on assets (ROA) |
3.8%
|
4.8%
|
6.5% |
Current ratio |
307.0%
|
416.3%
|
427.9% |
Return on equity (ROE) |
5.3%
|
4.3%
|
6.8% |
Change turnover |
2,662
|
-6,398
|
-16,307 |
Change turnover % |
6%
|
-14%
|
-26% |
Chg. No. of employees |
-2
|
-1
![]() |
-1 |
Chg. No. of employees % |
-11%
|
-5%
![]() |
-5% |
Total value of public sale
Fiscal year | 2023/03 | 2022/03 | 2021/03 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.